𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A case of poststreptococcal opsoclonus-myoclonus syndrome

✍ Scribed by Pooja Dassan; Charles Clarke; David J. Sharp


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
49 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

High antistreptococcal antibody titer (ASOT) was measured in a 31‐year‐old Caucasian lady presenting with opsoclonus and myoclonus. She was treated with oral steroids and 8 weeks after the onset of symptoms she had a normal ASOT and only mild residual symptoms. This is one of the first cases of opsoclonus‐myoclonus syndrome developing, following a streptococcal infection in adults. © 2007 Movement Disorder Society


📜 SIMILAR VOLUMES


Electrophysiological observations in idi
✍ Katrina A. Gwinn; Dr. John N. Caviness 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB

## Abstract To supplement existing knowledge regarding the pathophysiology of the opsoclonus‐myoclonus syndrome, electrophysiological findings are reported in three patients with idiopathic opsoclonus–myoclonus. Surface electromyography (EMG) revealed <100‐ms synchronous discharges correlating with

Full recovery of adult onset opsoclonus
✍ Stefan J. Groiss; Mario Siebler; Alfons Schnitzler 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Opsoclonus myoclonus syndrome (OMS) is a rare disease characterized by opsoclonus, an eye movement disorder causing involuntary, chaotic saccades in all directions, and arrhythmic action myoclonus often involving the trunk, limbs, and head. 1 Cerebellar dysfunction with dysarthria and ataxia as well

Electrophysiological evidence of cerebra
✍ Hiroshi Sakuma; Yuko Shimizu; Yoshiaki Saito; Kenji Sugai; Masumi Inagaki; Makik 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB

A correct balance between endocannabinoid and dopamine-dependent systems is believed to underlie physiological motor control. We measured the levels of the endocannabinoid anandamide in the cerebrospinal fluid of Parkinson's disease (PD) patients. Subjects were divided into three groups: newly diagn